Back to search
FDAFDA · Food and drugs·Recall number D-0145-2027

THYMOSIN ALPHA-1 (MDV) 3MG/ML **5ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas

Published November 11, 2026 · Recall initiated: October 19, 2026

Summary

FDA records drug Class II recall D-0145-2027, published November 11, 2026 and initiated October 19, 2026. Recalling firm: Victory Medical Center Pharmacy; Status: Ongoing; Reported quantity: 201 vials; Lot: Lot, expiry: Lot 2033588 , exp 11/3/2026; Lot 2044847 , exp 11/13/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Processing Controls

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Victory Medical Center Pharmacy
Distributor
CO, FL, TX
Lot
Lot, expiry: Lot 2033588 , exp 11/3/2026; Lot 2044847 , exp 11/13/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was THYMOSIN ALPHA-1 (MDV) 3MG/ML **5ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas recalled?

Yes. FDA published recall D-0145-2027 on November 11, 2026. Reported hazard: Lack of Processing Controls

What should I do if I have this product?

Voluntary: Firm initiated · Letter